Fidelity Advisor Biotechnology Fund ASND Holdings History
Fidelity Advisor Biotechnology Fund's Ascendis Pharma AS Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 434,425.00 shares of Ascendis Pharma AS(ASND), totaling $74.04 Mil. This investment constitutes 5.45% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.72% of the outstanding Ascendis Pharma AS(ASND) stock.
The initial trade took place in 2019Q4. And since then Fidelity Advisor Biotechnology Fund has made 8 purchases of ASND, at an average price of $108.38, for a total of 506,125.00 shares. In addition, there have been 2 sales at an average price of $125.05 for 71,700.00 shares. Based on historical transaction data and ASND's current price of $165.54, Fidelity Advisor Biotechnology Fund's estimated gain on his ASND holdings is $26.03 Mil, reflecting a 47.45% gain to date.
Fidelity Advisor Biotechnology Fund ASND ($165.54) Holding Chart
Fidelity Advisor Biotechnology Fund ASND ($165.54) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
